Biomec
VC Fund
Cleveland, United States
Biomec is a VC fund in Cleveland focused on Medical and Hardware. BIOMEC Inc., a biomedical device company based in Cleveland, OH, was established in 1998 with the objective of accelerating promising technology from major medical and academic institutions, national laboratories, and from internally developed proprietary products. BIOMEC built a highly effective engineering team with diverse capabilities inmedical device development, including mechanical design, software engineering, biocompatible coatings, and electronics.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Biomec invests in
Stages Biomec invests in
Countries Biomec invests in
Investment Focus
Industry
- Medical 1 (33%)
- Hardware 1 (33%)
- Health Care 1 (33%)
- Biotechnology 1 (33%)
- Medical Device 1 (33%)
Stage
- Series A 1 (33%)
- Series B 1 (33%)
- Funding Round 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Imalux Corporation
|
Imalux Corporation, an Ohio medical device company, is positioned to become the worldwide leader in the commercializationPhoto of medical imaging equipment and devices based on its proprietary Optical Coherence Tomography (OCT) technology. The Company’s products provide real-time, high spatial resolution imaging at the point-of-care in a variety ofmedical applications. OCT is a new imaging modality for visualization of tissue microstructure, especially in anatomical areas with stratified tissue. It has the ability to detect near-surface tissue abnormalities indicative of disease, which established imaging modalities might not detect. Many diseases, including cancer, are associated with superficial tissue structure disruption. Today, there is no commercialized in vivo method to visualize this tissue structure alteration; clinicians must do a biopsy and an ex vivo histopathological review using a conventional microscope. Imalux OCT products can be used to visualize structural disruptions in vivo at the point of care. | $4.8M / Series B / Jan 06, 2005 | |
|
Imalux Corporation
|
Imalux Corporation, an Ohio medical device company, is positioned to become the worldwide leader in the commercializationPhoto of medical imaging equipment and devices based on its proprietary Optical Coherence Tomography (OCT) technology. The Company’s products provide real-time, high spatial resolution imaging at the point-of-care in a variety ofmedical applications. OCT is a new imaging modality for visualization of tissue microstructure, especially in anatomical areas with stratified tissue. It has the ability to detect near-surface tissue abnormalities indicative of disease, which established imaging modalities might not detect. Many diseases, including cancer, are associated with superficial tissue structure disruption. Today, there is no commercialized in vivo method to visualize this tissue structure alteration; clinicians must do a biopsy and an ex vivo histopathological review using a conventional microscope. Imalux OCT products can be used to visualize structural disruptions in vivo at the point of care. | $3.5M / Series A / Sep 23, 2003 | |
|
NeuroControl Corporation
|
NeuroControl Corporation is a Health Care company. | Oct 18, 1999 |
Co-Investors
Early Stage Partners
2 deals together
Reservoir Venture Partners
2 deals together
BeyondTrust
1 deal together
Invacare
1 deal together
MCM Capital Partners
1 deal together
Morgenthaler Private Equity
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Biomec invest in?
Biomec invests primarily in Medical, Hardware and Health Care startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Biomec last invest?
The most recent investment recorded for Biomec closed in Jan 2005. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
